Revolution Medicines ergänzt RM-055 und erste Daten zur RAS-Studie.
Quelle: simplywall.st
Link: https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/revolution-medicines-adds-rm-055-and-first-line-data-to-ras